NCT00648141 - Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis | Biotech Hunter

Enrollment

458

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

January 31, 2005

Conditions

Spondylitis, Ankylosing

Interventions

DRUG

Celecoxib

200 mg oral capsule once daily for 12 weeks

DRUG

Celecoxib

200 mg oral capsule twice daily for 12 weeks

DRUG

Diclofenac

75 mg oral capsule twice daily for 12 weeks

Trial Locations (47)

10559

Pfizer Investigational Site, Berlin

10777

Pfizer Investigational Site, Berlin

12200

Pfizer Investigational Site, Berlin

12247

Pfizer Investigational Site, Berlin

13125

Pfizer Investigational Site, Berlin

14059

Pfizer Investigational Site, Berlin

17033

Pfizer Investigational Site, Neubrandenburg

18059

Pfizer Investigational Site, Rostock

21423

Pfizer Investigational Site, Winsen

25335

Pfizer Investigational Site, Elmshorn

26121

Pfizer Investigational Site, Oldenburg

26826

Pfizer Investigational Site, Weener

26903

Pfizer Investigational Site, Surwold

29223

Pfizer Investigational Site, Celle / OT Klein Hehlen

30161

Pfizer Investigational Site, Hanover

31134

Pfizer Investigational Site, Hildesheim

31848

Pfizer Investigational Site, Bad Münder am Deister

38723

Pfizer Investigational Site, Seesen

39104

Pfizer Investigational Site, Magdeburg

40211

Pfizer Investigational Site, Düsseldorf

42897

Pfizer Investigational Site, Remscheid

48431

Pfizer Investigational Site, Rheine

49074

Pfizer Investigational Site, Osnabrück

49186

Pfizer Investigational Site, Bad Iburg

51107

Pfizer Investigational Site, Cologne

51373

Pfizer Investigational Site, Leverkusen

52064

Pfizer Investigational Site, Aachen

53179

Pfizer Investigational Site, Bonn

64295

Pfizer Investigational Site, Darmstadt

65719

Pfizer Investigational Site, Hofheim

66111

Pfizer Investigational Site, Saarbrücken

68165

Pfizer Investigational Site, Mannheim

69120

Pfizer Investigational Site, Heidelberg

72076

Pfizer Investigational Site, Tübingen

78054

Pfizer Investigational Site, Villingen-Schwenningen

80336

Pfizer Investigational Site, München

83043

Pfizer Investigational Site, Bad Aibling

91056

Pfizer Investigational Site, Erlangen

D-10098

Pfizer Investigational Site, Berlin

09130

Pfizer Investigational Site, Chemnitz

Unknown

Pfizer Investigational Site, Dresden

Pfizer Investigational Site, Regensburg

06128

Pfizer Investigational Site, Halle

02977

Pfizer Investigational Site, Hoyerswerda

04107

Pfizer Investigational Site, Leipzig

01796

Pfizer Investigational Site, Pirna

D40882

Pfizer Investigational Site, Ratingen